(Reuters) - Valeant Pharmaceuticals International Inc , Canada's biggest public drugmaker, reported an 81 percent drop in third-quarter profit, and the company cut its profit forecast for the current quarter. Net income fell to $7.6 million, or 2 cents per share, from $40.9 million, or 13 cents per share, a year earlier. Total revenue rose 47 percent to $884.1 million. (Reporting by Bhaswati Mukhopadhyay in Bangalore and Allison Martell in Toronto; Editing by Sriraj Kalluvila) via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment